
TCM for Kidney Stones (Urolithiasis): Damp-Heat and Stone Strangury, Hydration First, the Jin Qian Cao Research, and the Red Flags That Need the ER (2026 Guide)
Cover image source: Pexels (photo by Engin Akyurt)
🌿 A gentle note from us
The practices shared here are rooted in Traditional Chinese Medicine traditions that have been passed down for thousands of years. We share them as educational resources — not as prescriptions or medical advice.
Every body is different. What brings balance to one person may not be right for another. Please listen to your body, go gently, and check with a qualified healthcare provider before trying any new wellness practice — especially if you are pregnant, managing a chronic condition, or have specific health concerns.
Some links on this site are affiliate links. If you choose to purchase through them, we may earn a small commission at no extra cost to you. This helps us continue sharing ancient wisdom for modern wellness. Thank you for your trust.
Early autumn, familiar pain, better priorities
Kidney stones affect roughly 9.25% of US adults, about 1 in 11, in an NHANES analysis of 37,857 adults from 2007 to 2020. Prevalence among women rose from 6.5% to 9.1%; overall prevalence remained broadly stable, from 8.9% in 2007–2008 to 9.9% in 2017–2020. It peaked at 23.9% among adults aged 70 and older. NHANES paper
The AUA’s 2026 guideline describes lifetime disease affecting as many as one in nine US adults, with recurrence after a first stone of 20–67% at 5–10 years in adults and 50% at 3 years in children. AUA guideline
Presentations rise in summer and early fall. A 2018 seasonal study examined urinary calcium, volume, and vitamin D; it described 80% of stones as predominantly calcium based: calcium oxalate 70%, calcium phosphate 10%. After low urine volume, high urinary calcium was the most common abnormality in recurrent stone formers. Seasonal study
Here is a practical way through the TCM language and research: evaluate, hydrate, then consider adjuncts. The promising herbal evidence deserves attention, but so do its limits.
This is not just a pain story
The AUA places stones within a wider systemic health picture, associated with type 2 diabetes, hypertension, obesity, cardiovascular disease, chronic kidney disease, and bone loss. Shared risk factors may explain these associations; they do not establish causation. The recommendation is an overall healthful approach. AUA guideline
A 2024 review reports recurrence around 35–50% after first renal colic. Over 5 years, approximately 19% had symptomatic recurrence needing clinical care, approaching 30% when self-managed episodes counted. Including imaging findings increased a first-stone recurrence estimate from 30% to 67%. At 5 years, 35% formed a new stone, 24% had a retained stone enlarge, and 26% passed a retained stone. These measures describe different events, rather than interchangeable forecasts. Recurrence review
Metabolic evaluation considers hypercalciuria, hyperoxaluria, hypocitraturia, and metabolic acidosis. Hypocitraturia, meaning low urinary citrate, has an estimated prevalence of 20–60% among stone formers. StatPearls
What is the stone made of?
The following ranges come from a 2026 Frontiers in Pharmacology review; composition helps frame prevention. Review
| Stone type | Share | Notes |
|---|---|---|
| Calcium oxalate | ~70–80% | Mainly monohydrate (COM, whewellite) and dihydrate (COD, weddellite). Source |
| Calcium phosphate | ~10–15% | Carbonate apatite and brushite; linked with distal renal tubular acidosis, primary hyperparathyroidism, or alkaline urine, pH > 6.5. Source |
| Uric acid | ~8–10% | Associated with hyperuricosuria, metabolic syndrome, and acidic urine, pH < 5.5. Source |
| Struvite / infection | ~1–5% | Magnesium ammonium phosphate; urease-producing bacteria such as Proteus mirabilis promote precipitation. Source |
| Cystine | ~1% | Autosomal recessive impairment of renal dibasic amino acid reabsorption, involving SLC3A1/SLC7A9 mutations. Source |
China Medical University Hospital puts calcium oxalate at about 75%, consistent with that range. CMUH
How TCM describes stone strangury
Traditional accounts place kidney, ureter, and bladder stones within 淋證 (lin zheng), urinary straining disorders: specifically 石淋 (shi lin), stone strangury, or 砂淋 (sha lin), sand strangury. Prominent bleeding falls under 血淋 (xue lin). Medical encyclopedia
The Sui-dynasty 諸病源候論 (Zhubing Yuanhou Lun) connected kidney deficiency with bladder heat, 腎虛而膀胱熱. Its description included painful, incomplete urination, pain drawing into the lower abdomen, and sand or stones passing in urine. Traditional presentations also include flank or lower-back pain radiating downward, interrupted flow, urgency, frequency, cloudiness, and blood. Medical encyclopedia
Modern patterns include lower-jiao damp-heat (下焦濕熱), qi stagnation with blood stasis (氣滯血瘀), spleen-kidney deficiency (脾腎虧虛), and liver qi stagnation (肝氣鬱滯). CMUH, encyclopedia
Pattern language describes a presentation; it does not diagnose a stone. A clinician and imaging establish its presence, size, and location. AUA guideline
Historically associated herbs include Jin Qian Cao (金錢草), Hai Jin Sha (海金沙, Lygodium spore), Shi Wei (石韋, Pyrrosia leaf), Ji Nei Jin (雞內金), Che Qian Zi (車前子), Hua Shi (滑石), Qu Mai (瞿麥), and Wang Bu Liu Xing (王不留行). The encyclopedia describes Jin Qian Cao becoming a leading stone herb from the 1960s onward. This is historical context, not a prescription. Encyclopedia
CMUH advises 2,000–3,000 mL daily, spread throughout the day, with more during sweating, heat, fever, diarrhoea, or after exercise. It favors plain water, avoiding delayed urination, limiting salt and excessive meat or beans, and moderating listed high-oxalate foods: chocolate, nuts, dark green vegetables, tofu, tea, and cola. Individual medical advice takes priority. CMUH
Jin Qian Cao: the strongest herbal signal, with limits
What the phase 3 trial tested
A 2026 phase 3 randomized clinical trial, published in JAMA Network Open on September 9, 2026, tested Guang Jing Qian Cao, Desmodium styracifolium total flavone capsules, an extract associated with Jin Qian Cao. It was double-blind and placebo-controlled: DOI 10.1001/jamanetworkopen.2026.32874, PubMed 42714908, registration ChiCTR-IIR-17013275. Trial, PubMed
Across 34 Chinese sites, from December 2017 to April 2020, 606 participants with 5 to 10 mm ureteral stones were randomized 3:1. Mean age was 43.0 years (SD 12.0); 78.2% were male; mean stone size was 0.6 cm (SD 0.1). Treatment was 0.6 g orally three times daily for 28 days, versus matching placebo, alongside investigator-prescribed background medication. This describes the research regimen, not home-use instructions. Trial
| Outcome | Extract | Placebo | Interpretation |
|---|---|---|---|
| CT-confirmed passage by day 28 | 44.6% (204 of 457) | 33.8% (50 of 148) | Relative risk 1.32; 95% CI 1.03–1.69; P = .03. Trial |
| Passage by day 14 | 29.1% | 22.3% | P = .14; not significant. Trial |
| Mean migration distance | 29.5 mm (SD 51.8) | 29.7 mm (SD 43.8) | P = .11; not significant. Trial |
| Adverse events | 19.3% | 18.2% | Similar observed rates. Trial |
The primary outcome’s absolute difference was 10.9 percentage points (95% CI 2.0–19.7). Yet 253 participants (55.4%) receiving extract and 98 (66.2%) receiving placebo lacked confirmed passage by day 28. The authors considered this modest benefit most relevant to appropriately selected patients. Trial
Selection mattered: enrollment required TCM damp-heat accumulation, with at least two features among urethral burning, lower-back pain, and hematuria. Everyone received background medication. Results therefore concern a particular extract and selected population under clinical supervision. Trial
The authors compared the effect size broadly with alpha-blockers, described as AUA/EAU mainstay expulsive therapy, particularly for distal ureteral stones larger than 5 mm. They noted dizziness, hypotension, and abnormal ejaculation, alongside the lack of significant overall placebo advantage in the large SUSPEND and STONE tamsulosin trials. This contextual comparison does not establish equivalence. Trial discussion
Earlier evidence remains uncertain
A 2023 Journal of Clinical Urology double-blind, placebo-controlled study at Hubei Provincial Hospital of Traditional Chinese Medicine enrolled 66 patients with ureteral calculi. Passage occurred in 25 of 48 (52.08%) versus 4 of 18 (22.22%), P = 0.029; TCM symptom scores also favored treatment. Adverse events occurred in 8.33% versus 0%, with no serious events. Earlier trial
A 2016 systematic review screened 541 articles and included 16 randomized trials. Citrate outperformed phytotherapy for stone-size reduction and urinary urate excretion; stone size averaged 0.42 mm higher with phytotherapy, 95% CI 0.23–0.6. A Didymocarpus pedicellata combination was superior to placebo for total stone clearance, risk ratio 6.19 (95% CI 2.60–14.74), and for size reduction at 3 months. Every trial had high risk of bias across multiple Cochrane domains. Low-quality evidence sharply limits conclusions. Systematic review
A Chinese-language meta-analysis of oral herbs plus extracorporeal shock wave lithotripsy included 18 studies and 3,131 patients. Reported total effectiveness favored combination care, but heterogeneity was I² = 93.24%; no included study reported blinding or allocation concealment. The authors requested better double-blind trials. Treat this as low-certainty evidence. Meta-analysis
Acupuncture for renal colic: emergency-department evidence
An August 2022 JAMA Network Open randomized trial, with corresponding author Cun-Zhi Liu, Beijing University of Chinese Medicine, enrolled 80 emergency-department patients, with baseline VAS pain scores ≥ 4. All received intramuscular diclofenac, then 30 minutes of real or sham acupuncture, 40 per group. Trial
At 10 minutes, a pain-score reduction of at least 50% occurred in 77.5% versus 10.0%, P < .001. Responses also favored acupuncture at 0, 5, 15, 20, and 30 minutes, but not significantly at 45 or 60 minutes. Rescue analgesia needs did not differ significantly; neither group reported adverse events. Trial
A 2023 Frontiers in Medicine meta-analysis and trial sequential analysis by Chen HT et al., Chi Mei Medical Center, Taiwan, concluded that acupuncture relieved colic more efficiently, with fewer adverse effects, than conventional analgesic-based interventions. Meta-analysis
The emergency-department trial tested practitioner needling alongside analgesia. It does not establish benefit from self-acupressure or replace assessment, imaging, or pain medication. Trial
What to do, in priority order
Get the diagnosis
Have a clinician establish the stone’s size and location with imaging. Stones under 5 mm usually pass spontaneously; larger stones may require intervention. Trial context
Put urine volume first
The AUA’s 2026 guideline recommends enough fluid to produce at least 2.5 liters of urine daily, a Standard, Grade B recommendation. Urine volume determines the concentration of stone-forming substances; fluid intake largely determines urine volume. AUA guideline
NIDDK commonly suggests six to eight 8-ounce glasses daily, mainly water, with individual advice for kidney failure. Stone formers may need more to meet the AUA urine-output standard. Confirm your target with your clinician. NIDDK
Reduce sodium
For calcium stones with relatively high urinary calcium, AUA advises sodium restriction, targeting 100 mEq (2,300 mg) daily, while maintaining 1,000–1,200 mg/day dietary calcium. AUA PDF
NIDDK advises adults to stay below 2,300 mg sodium daily; a teaspoon of table salt contains 2,325 mg. NIDDK
Keep dietary calcium
In a five-year trial cited by AUA, men with calcium oxalate stones and idiopathic hypercalciuria had 51% lower recurrence risk on 1,200 mg/day calcium with lower animal protein and sodium than on 400 mg/day calcium. The result concerns the combined diet. AUA PDF
Dietary calcium is consistently associated with lower risk; supplements may increase risk. For hyperoxaluria, calcium-containing foods at meals bind intestinal oxalate, within 1,000–1,200 mg daily. AUA PDF
Tailor oxalate and protein
When stone type and urine findings warrant restriction, NIDDK lists nuts, nut products, peanuts, rhubarb, spinach, and wheat bran as high-oxalate concerns. Animal protein includes beef, chicken, pork, especially organs, eggs, fish, shellfish, milk, and dairy. Beans, dried peas, and lentils offer low-oxalate protein alternatives. Plan changes individually rather than applying every restriction. NIDDK
Support citrate
Urinary citrate inhibits calcium stone formation. Acid loads reduce citrate excretion; low-citrate patients should increase fruit and vegetables and limit non-dairy animal protein. Acid-producing foods include meat, fish, poultry, cheese, eggs, and, less strongly, grains. AUA PDF
Many clinicians target at least 600 mg urinary citrate daily; some use 500–600 mg. About 20% of hypocitraturia patients resist citrate supplementation, reinforcing the need for follow-up. AUA PDF, StatPearls
Leave prescriptions to your clinician
AUA recommends potassium citrate for recurrent calcium stones with low urinary citrate, and for uric acid or cystine stones, targeting urine pH 6.0 or 7.0, respectively. Potassium is preferred over sodium citrate because sodium can raise urinary calcium. AUA PDF
Allopurinol is offered for recurrent calcium oxalate stones with hyperuricosuria and normal urinary calcium. It is not routine first-line uric acid stone treatment: low urine pH usually dominates. Thiazides may be offered when stones persist after other abnormalities are addressed. Do not start these medicines yourself. AUA PDF
Metabolic testing uses one or two 24-hour urine collections, measuring volume, pH, calcium, oxalate, uric acid, citrate, sodium, potassium, and creatinine. AUA PDF
Acupressure: comfort only
Acupressure does not dissolve, break up, or expel a kidney stone; no protocol has been shown to do so. The cited acupuncture evidence concerns needling, not pressure points. Acupuncture trial
Reserve gentle pressure and warmth for general comfort or relaxation between episodes or alongside prescribed care. Do not treat them as renal-colic treatment, and never delay emergency care to try pressure points. Sepsis Alliance
Commonly used comfort points include:
- BL23, Shenshu: lower back, 1.5 cun lateral to the lower border of the L2 spinous process; have a practitioner identify it rather than guessing.
- BL28, Pangguangshu: on the sacrum; request professional guidance for precise placement.
- KI3, Taixi: behind the inner ankle.
- SP6, Sanyinjiao: about 4 finger-widths above the inner ankle bone, behind the shin bone.
Use comfortable pressure for 20–30 seconds while breathing slowly. Stop immediately if anything hurts. Avoid lower-back pressure, or keep it very gentle, if touch causes severe pain. Pregnant or possibly pregnant readers should not self-treat SP6 without professional advice. These are comfort precautions, not a stone-treatment protocol. Related comfort guide
Herbs, products, and kidney safety
NCCIH warns that TCM products may contain undeclared drugs, heavy metals, pesticides, or incorrectly identified ingredients; herbs may interact with prescriptions. NCCIH
FDA Import Alert 54-10 identifies aristolochic acid in Aristolochiaceae botanicals as a potent carcinogen and nephrotoxin. Renal-failure outbreaks involved misidentified ingredients or name confusion. Small exposures may seem harmless for years before serious, irreversible kidney damage becomes apparent. FDA alert
Taiwan’s Department of Health banned five aristolochic-acid-containing herbal drugs in 2003: Aristolochia fangchi, A. manshuriensis, A. debilis, Herba Aristolochia, and A. heterophylla. It cancelled 69 product licences, citing confirmed kidney-failure links. Taipei Times
Use these practical boundaries:
- Never buy online products advertised as “stone-dissolving” or “stone-clearing.” FDA safety context
- Work only with a licensed TCM practitioner; disclose every medicine and supplement. NCCIH
- Tell both practitioners about reduced kidney function, a single kidney, transplant, diabetes, hypertension, pregnancy, or breastfeeding. Continue prescribed care. NCCIH
Emergency warning signs
Do not wait, and do not manage fever with a stone at home. Infection behind an obstruction can progress to sepsis. Sepsis Alliance
Seek emergency assessment for:
- Fever ≥ 100.4°F (38°C), especially chills, with flank/back pain or a known stone. Sepsis Alliance
- Severe pain uncontrolled by over-the-counter medication, repeated vomiting, or inability to keep fluids down. Sepsis Alliance
- Visible urinary blood with fever, severe pain, or clots blocking urination. Sepsis Alliance
- Suspected stone symptoms during pregnancy, or with a single kidney, kidney transplant, or known kidney failure. Sepsis Alliance
| Situation | Action |
|---|---|
| Fever with flank pain or a known stone | Go to the emergency department immediately. Source |
| Confusion, drowsiness, trouble speaking, fainting, very fast heart rate, low blood pressure, or barely passing urine | Possible urosepsis: call emergency services. Source |
Your next practical step
Discuss a personal fluid target and prevention plan using NIDDK’s diet guidance, the AUA 2026 guideline, and NCCIH’s TCM safety page.
For related reading, the recurrent UTI guide explores lower-jiao damp-heat language. Follow uric acid questions into the gout and high uric acid guide, and traditional kidney concepts into kidney health and jing.
For other concerns to discuss at appointments, see the enlarged prostate guide and diabetes and blood sugar guide. The body clock guide offers further background on traditional pattern language.
Stones recur; urine volume is the most actionable prevention lever. AUA guideline The 2026 Jin Qian Cao trial is the most credible herbal signal discussed here, but its benefit was modest and tested under clinician supervision alongside standard care. Trial Fever with flank pain ends self-care immediately. Sepsis Alliance
TCM approaches are complementary and must not delay medical assessment or treatment.